630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study

التفاصيل البيبلوغرافية
العنوان:	630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study
المؤلفون:	Salvatore Grisanti, Vivek Subbiah, Eric Baudin, Gedske Daugaard, Alfredo Berruti, Jennifer Martinez, Camilo Jimenez, Harm Haak, Jerome Kervevan, Lucie Aubergeon, Chloé Ventujol, Christophe Bonny, Laurent Chene, Joao Gamelas Magalhaes, CWillemien Menke-vander Houven van Oordt, Martin Fassnacht, Jaume Capdevila, Christelle de la Fouchardière, Dan Granberg, Matthias Kroiss, Hélène Toussaint, Camille Belyn, Jean-Michel Paillarse
المصدر:	Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
بيانات النشر:	BMJ Publishing Group, 2023.
سنة النشر:	2023
المجموعة:	LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2051-1426
Relation:	https://doaj.org/toc/2051-1426
DOI:	10.1136/jitc-2023-SITC2023.0630
URL الوصول:	https://doaj.org/article/1813b161c9924e2fafbf6152abc5c0c2
رقم الأكسشن:	edsdoj.1813b161c9924e2fafbf6152abc5c0c2
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	20511426
DOI:	10.1136/jitc-2023-SITC2023.0630